CN109529012A - A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and application - Google Patents

A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and application Download PDF

Info

Publication number
CN109529012A
CN109529012A CN201910024961.9A CN201910024961A CN109529012A CN 109529012 A CN109529012 A CN 109529012A CN 201910024961 A CN201910024961 A CN 201910024961A CN 109529012 A CN109529012 A CN 109529012A
Authority
CN
China
Prior art keywords
pheretima
metal oxide
oxide nano
bletilla striata
albumen composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910024961.9A
Other languages
Chinese (zh)
Inventor
王东
谷婷
权珍妮
王瑞辉
王雪静
张晓叶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi University of Chinese Medicine
Original Assignee
Shaanxi University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi University of Chinese Medicine filed Critical Shaanxi University of Chinese Medicine
Priority to CN201910024961.9A priority Critical patent/CN109529012A/en
Publication of CN109529012A publication Critical patent/CN109529012A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6953Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a fibre, a textile, a slab or a sheet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention discloses a kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and applications, prepare pheretima stress protein, layered metal oxide nano-carrier is prepared, metal oxide nano bletilla striata pheretima albumen composition is prepared, the compound is applied in rat brain injury reparation.Compared with prior art, the present invention enters the effective component self assembly of pheretima stress protein and bletilla in stratified nano materials, it is a kind of with sustained release, economic medical preparation to be prepared for, the degradation of albumen and the oxidational losses of traditional Chinese medicine ingredients are also effectively reduced while saving drug effect, have been finally reached the purpose for promoting craniocerebral injury rehabilitation.

Description

A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and application
Technical field
The present invention relates to animal protein and vegetable drug nano traditional Chinese medicine compound preparation technical field, especially a kind of metal Oxidate nano bletilla striata pheretima albumen composition preparation method and application.
Background technique
Craniocerebral injury is a kind of common damage of modern society, especially in traffic accident case.Patient is due to external object Shock of the body to brain, seriously destroys the normal function of brain, so as to cause the temporarily or permanently cognition of property, physiology and the heart In function forfeiture.Craniocerebral injury at present has become the primary cause of disease dead and disabled in 45 years old or less crowd.Chinese traditional medicine sleeper Albumen is it is verified that the proliferation and differentiation of wound tissue's cell can be effectively facilitated, the ability of acceleration of wound healing.But because It is ground dragon protein as a kind of large biological molecule, is very easy to that protein degradation occurs, there is consumption in actual use The problems such as amount is big, and economic cost is high.The bletilla striata has astringing to arrest bleeding on herbal pharmacology, and the effect of detumescence and promoting granulation, but it is in reality It is excessive that there is also consumptions in the use of border, it is difficult to the problems such as merchandized handling.
It would therefore be highly desirable to develop a kind of metal oxide nano bletilla striata pheretima albumen composition.
Summary of the invention
The invention aims to solve the deficiencies in the prior art, a kind of metal oxide nano bletilla striata is provided Dragon protein compound preparation method and application.
In order to achieve the above objectives, the present invention is implemented according to following technical scheme:
A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method, comprising the following steps:
S1, preparation pheretima stress protein:
Fresh and alive pheretima is cleaned repeatedly with 0.9% NaCl solution, removes body surface dirt, the pheretima after cleaning is at 25 DEG C Under be placed in and allow within 4 hours in the normal saline solution of the continuous oxygen system of sky air pump its internal silt of spuing;With water suction after pulling out Paper removes surface moisture and is transferred in beaker;It is quickly stirred with glass bar rapidly after the sucrose of pheretima total weight 10% is added Even, waiting the yellow-green liquid collected in beaker after 10min is pheretima stress protein, the anti-protein degradation enzyme of 1X is added, so The NaN that concentration is 0.02% is added afterwards3Pheretima stress protein liquid is obtained as preservative, is stored spare;
S2, layered metal oxide nano-carrier is prepared
Weigh the Ni (NO of 6mmol3)2It is added in 300ml water after mixing constantly with the dodecyl sodium sulfate of 30mmol It is stirred overnight, is then transferred in hydrothermal synthesis reaction kettle, natural cooling after reaction kettle is heated to 110 DEG C of reactions 16 hours;It crosses The mixed liquor of the product obtained after filter ethyl alcohol and water is rinsed to the colourless postposition of washing lotion in a vacuum drying oven, dry at 70 DEG C 12 hours, resulting powder and 10g Na2HPO4Porcelain boat is put into tube furnace after being put into porcelain boat two sides, wherein NaH2PO4One end It is placed on air inlet side, powder sample one end is placed on tube furnace gas outlet side, N2It is natural after being heated to 350 DEG C under environment Cooling obtains NiP layered metal oxide nano-carrier;
S3, metal oxide nano bletilla striata pheretima albumen composition is prepared
The 10g bletilla striata is weighed, is filtered after decocting half an hour with deionized water, utilizes Rotary Evaporators removing more after collecting solution Gained pasty mass is freeze-dried by remaining moisture, collects bletilla striata extract powder;By gained bletilla striata extract powder and S1 In the pheretima stress protein liquid that is prepared be mixed to get pheretima stress protein mixed liquor, it is rear 2 times of pheretimas then are added stress The concentration of mixed liquid of protein volume is that the Tris-HCl buffer that 20mM, pH are 7.2 obtains mixed liquor;Measure mixed liquor 20ml with 5.0gNiP layered metal oxide nano-carrier mixes, and stirs 8 hours at 4 DEG C;It is centrifuged mixed liquor and collects precipitating, freeze-drying Collect powder afterwards to get metal oxide nano bletilla striata pheretima albumen composition is arrived.
Further, pheretima selects Eisenia Foetida in the S1.
Further, the volume ratio of ethyl alcohol and water is 1:1 in the S2.
Further, bletilla striata extract powder carries out mixing system according to mass ratio 1:1 with pheretima stress protein liquid in the S3 Obtain pheretima stress protein mixed liquor.
In addition, the present invention also provides a kind of application of metal oxide nano bletilla striata pheretima albumen composition, use is above-mentioned Metal oxide nano bletilla striata pheretima albumen composition made from preparation method is used as rat brain injury repair medicine.
The principle of the present invention are as follows: the slow of ground dragon protein effective component is controlled by NiP layered metal oxide nano-carrier On The Drug Release achievees the purpose that medicament-saving consumes, and NiP layered metal oxide nano-carrier has blocked ground dragon protein effective component With extraneous contact, to effectively inhibit the degradation of protein ingredient and the oxidation of effective ingredient, metal oxygen produced by the present invention Compound nanometer bletilla striata pheretima albumen composition can promote the proliferation of cell, nerve cell is promoted to restore regeneration and restore, therefore, can As rat brain injury repair medicine.
Compared with prior art, the effective component self assembly of pheretima stress protein and bletilla is entered stratiform and received by the present invention In rice material, to be prepared for a kind of with sustained release, economic medical preparation, also effective drop while saving drug effect The low degradation of albumen and the oxidational losses of traditional Chinese medicine ingredients have been finally reached the purpose for promoting craniocerebral injury rehabilitation.
Detailed description of the invention
Fig. 1 is the characterization of NiP layered metal oxide nano-carrier made from the embodiment of the present invention;A is 2000 times of amplification NiP layered metal oxide nano-carrier electronics surface sweeping MIcrosope image;B is the laminated metal the NiP oxygen for amplifying 10000 times The electronics surface sweeping MIcrosope image of compound nano-carrier;C is the X-ray powder diffraction of NiP layered metal oxide nano-carrier Figure;D is the medicament slow release experimental result of NiP layered metal oxide nano-carrier.
Fig. 2 is the H&E coloration result of the Damage of Rats position Cerebral cortex in application example;(a) it is blank group, is (b) multiple Close object group.
Fig. 3 is the Nissl's staining result of the Damage of Rats position Cerebral cortex in application example;(a) it is blank group, is (b) multiple Close object group.
Fig. 4 is the Apoptosis result of the Damage of Rats position Cerebral cortex in application example;(a) it is blank group, is (b) multiple Close object group.
Specific embodiment
To make the objectives, technical solutions, and advantages of the present invention more comprehensible, with reference to embodiments, to the present invention into Row is further to be described in detail.Described herein the specific embodiments are only for explaining the present invention, is not used to limit invention.
A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method of the embodiment of the present embodiment, including it is following Step:
S1, preparation pheretima stress protein:
Fresh and alive pheretima (Eisenia Foetida) is cleaned repeatedly with 0.9% NaCl solution, body surface dirt is removed, after cleaning Pheretima be placed at 25 DEG C and allow within 4 hours in the normal saline solution of the continuous oxygen system of sky air pump its internal silt of spuing; Surface moisture is removed with blotting paper after pulling out and is transferred in beaker;Glass is used rapidly after the sucrose of pheretima total weight 10% is added Stick quickly stirs evenly, and waiting the yellow-green liquid collected in beaker after 10min is pheretima stress protein, and the anti-egg of 1X is added Then the NaN that concentration is 0.02% is added in white degrading enzyme3Pheretima stress protein liquid is obtained as preservative, is stored spare;
S2, layered metal oxide nano-carrier is prepared
Weigh the Ni (NO of 6mmol3)2It is added in 300ml water after mixing constantly with the dodecyl sodium sulfate of 30mmol It is stirred overnight, is then transferred in hydrothermal synthesis reaction kettle, natural cooling after reaction kettle is heated to 110 DEG C of reactions 16 hours;It crosses The mixed liquor of ethyl alcohol and water that the product obtained after filter is 1:1 with volume ratio rinses to washing lotion is colourless and is placed on vacuum oven In, 12 hours dry at 70 DEG C, resulting powder and 10g Na2HPO4Porcelain boat is put into tube furnace after being put into porcelain boat two sides, Wherein NaH2PO4One end is placed on air inlet side, and powder sample one end is placed on tube furnace gas outlet side, N2Add under environment Heat to natural cooling after 350 DEG C obtains NiP layered metal oxide nano-carrier;
S3, metal oxide nano bletilla striata pheretima albumen composition is prepared
The 10g bletilla striata is weighed, is filtered after decocting half an hour with deionized water, utilizes Rotary Evaporators removing more after collecting solution Gained pasty mass is freeze-dried by remaining moisture, collects bletilla striata extract powder;By gained bletilla striata extract powder and S1 In the pheretima stress protein liquid that is prepared be mixed to get pheretima stress protein mixed liquor according to mass ratio 1:1, it is rear to be then added 2 The concentration of times pheretima stress protein mixeding liquid volume is that the Tris-HCl buffer that 20mM, pH are 7.2 obtains mixed liquor;It measures Mixed liquor 20ml is mixed with 5.0gNiP layered metal oxide nano-carrier, is stirred 8 hours at 4 DEG C;It is centrifuged mixed liquor and collects and sink It forms sediment, powder is collected after freeze-drying to get metal oxide nano bletilla striata pheretima albumen composition is arrived.
The sustained release performance of NiP layered metal oxide nano-carrier is tested: compound concentration 0.4mg/ml, BSA Tris-HCl (pH=7.2) buffer of 0.8mg/ml, 1.2mg/ml, 1.6mg/ml and 2.0mg/ml utilize Nanodrop (2000C) measures its light absorption value OD280nm at 20 DEG C at 280nm respectively, is calculated by linear regression It is A=0.065C+0.001 to the linear relationship of light absorption value and protein concentration, wherein A is light absorption value, and C is protein concentration, Coefficient R 2=0.9991.Weigh the Tris-HCl of 2.0g metal oxide nano bletilla striata pheretima albumen composition mixing 4ml (pH=7.2) it is placed in shaking table at 4 DEG C after buffer, every 30min with pipetting after hand held centrifuge rapid centrifugation 60s 200ul supernatant measures its OD280nm, and it is slow that fresh 200ul Tris-HCl (pH=7.2) is supplemented into system after measurement every time Fliud flushing.
Fig. 1 a and Fig. 1 b are scanning electron microscope (SEM) figure of prepared NiP layered metal oxide nano-carrier Picture, wherein the amplification factor of Fig. 1 a is 2000 times, and the amplification factor of Fig. 1 b is 10000 times.Morphology observation is it can be found that prepared NiP layered metal oxide nano-carrier accumulated by sheet, constructed stephanoporate framework in space, entire material is in space point Cloth is substantially uniform.Through measuring, these channel diameters are 800 ± 400nm, and the ground dragon protein that exists for further loading in duct provides Space.SEM Surface energy spectrum analysis confirms that the atomic percent of Ni atom and P atom is about 1:1 in material.Fig. 1 c is NiP layers There is apparent diffraction at 20 °, 26 °, 33 °, 59 ° and 73 ° in the X-ray powder diffraction figure of shape metal oxide nano carrier Peak thinks that the atomic percent of Ni atom and P atom in 1:1 or so, illustrates to have had successfully been obtained NiP layers afterwards compared with document Shape metal oxide nano carrier.
Dotted line describes the variation feelings in NiP nanometer earthworm albumen composition protein concentration in buffer solution system in Fig. 1 d Condition, and block curve is then that protein concentration is managed in buffer when not having pharmaceutical carrier to participate in situation under identical initial protein concentration By situation of change.If apparent as can be seen that being participated in without NiP layered metal oxide nano-carrier, theoretically on 9 hours left sides Concentration in right system is lower than 0.02mg/ml, and this time can be extended to 14 small for NiP nanometer earthworm albumen composition When or so, increase 55%.Illustrate that the compound has preferable albumen slow-release capability.
Application Example
S1,60 (220 ± 10g) SD rats are taken to be randomly divided into compound rat group (30) and blank using the same manner Groups of control (30);
Before S2, modeling to SD rat carry out 6 hours fasting for solids and liquids, later to rat using intraperitoneal injection yellow Jackets into Row anesthesia, shave rat crown hair, hit using cranium brain striking device rat brain: blow speed 5.30m/s is beaten Depth 4.5mm is hit, residence time 400ms is hit.Gentamicin sulphate 6 is instilled to wound with 2ml injection to drip, and utilizes hand Art needle sutures rat scalp.All experimental mouses carry out single cage raising, and feeding environment temperature is 25 DEG C;
S3, the nanometer earthworm albumen composition 5.0g being prepared is uniformly mixed with the 0.9% of 20ml NaCl solution Afterwards respectively at wound the 1st day, stomach-filling is carried out to rat oral chamber within the 4th day, the 7th day and 15 days, each stomach-filling 2ml, one time a day; Physiological saline is perfused in blank group;Rat is put to death with carbon dioxide smother play after 15 days, and takes damage location Cerebral cortex according to reagent Box operation instructions carry out H&E dyeing, Nissl's staining and Apoptosis test result respectively such as Fig. 2, Fig. 3, Fig. 4.
In Fig. 2, spot indicates nucleus, and the number of cell in tissue is determined using the distribution situation of observation nucleus Amount.By observation, it can be seen that, in compound group, spot is more, illustrates that the cell quantity in compound group is greater than blank group, To prove that compound group can promote the proliferation of cell.
In Fig. 3, each circle is a neuronal cell, and the quantity in compound group is higher than blank group, is illustrated logical The treatment of compound is crossed, the nerve cell recovery effects in the Cerebral cortex of rat are preferable.Compound, which has, promotes nerve cell to restore Regenerated ability.
In Fig. 4, light tone spot represents the cell of apoptosis.Light tone spot in blank group is significantly more than compound Group illustrates the treatment by compound, and the apoptosis situation in tissue is reduced, and compound can promote cell to restore.
The limitation that technical solution of the present invention is not limited to the above specific embodiments, it is all to do according to the technique and scheme of the present invention Technology deformation out, falls within the scope of protection of the present invention.

Claims (5)

1. a kind of metal oxide nano bletilla striata pheretima albumen composition preparation method, which comprises the following steps:
S1, preparation pheretima stress protein:
Fresh and alive pheretima is cleaned repeatedly with 0.9% NaCl solution, removes body surface dirt, the pheretima after cleaning is underlying at 25 DEG C Allow within 4 hours in the normal saline solution for having the continuous oxygen system of air pump its internal silt of spuing;It is removed after pulling out with blotting paper It removes surface moisture and is transferred in beaker;It is quickly stirred evenly with glass bar rapidly after the sucrose of pheretima total weight 10% is added, Wait 10min after collect beaker in yellow-green liquid be pheretima stress protein, the anti-protein degradation enzyme of 1X is added, then plus Enter the NaN that concentration is 0.02%3Pheretima stress protein liquid is obtained as preservative, is stored spare;
S2, layered metal oxide nano-carrier is prepared
Weigh the Ni (NO of 6mmol3)2It is added in 300ml water and is stirred continuously after mixing with the dodecyl sodium sulfate of 30mmol Overnight, it is then transferred in hydrothermal synthesis reaction kettle, natural cooling after reaction kettle is heated to 110 DEG C of reactions 16 hours;After filtering The mixed liquor of obtained product ethyl alcohol and water is rinsed to the colourless postposition of washing lotion in a vacuum drying oven, and dry 12 is small at 70 DEG C When, resulting powder and 10g Na2HPO4Porcelain boat is put into tube furnace after being put into porcelain boat two sides, wherein NaH2PO4It places one end In air inlet side, powder sample one end is placed on tube furnace gas outlet side, N2Natural cooling after being heated to 350 DEG C under environment Obtain NiP layered metal oxide nano-carrier;
S3, metal oxide nano bletilla striata pheretima albumen composition is prepared
The 10g bletilla striata is weighed, is filtered after decocting half an hour with deionized water, utilizes Rotary Evaporators removing superfluous water after collecting solution Point, gained pasty mass is freeze-dried, bletilla striata extract powder is collected;It will be made in gained bletilla striata extract powder and S1 Standby obtained pheretima stress protein liquid is mixed to get pheretima stress protein mixed liquor, rear that 2 times of pheretima stress proteins are then added The concentration of mixeding liquid volume is that the Tris-HCl buffer that 20mM, pH are 7.2 obtains mixed liquor;Measure mixed liquor 20ml with 5.0gNiP layered metal oxide nano-carrier mixes, and stirs 8 hours at 4 DEG C;It is centrifuged mixed liquor and collects precipitating, freeze-drying Collect powder afterwards to get metal oxide nano bletilla striata pheretima albumen composition is arrived.
2. metal oxide nano bletilla striata pheretima albumen composition preparation method according to claim 1, it is characterised in that: Pheretima selects Eisenia Foetida in the S1.
3. metal oxide nano bletilla striata pheretima albumen composition preparation method according to claim 1, it is characterised in that: The volume ratio of ethyl alcohol and water is 1:1 in the S2.
4. metal oxide nano bletilla striata pheretima albumen composition preparation method according to claim 1, it is characterised in that: Bletilla striata extract powder and pheretima stress protein liquid carry out being mixed to prepare pheretima stress protein mixed according to mass ratio 1:1 in the S3 Close liquid.
5. a kind of application of metal oxide nano bletilla striata pheretima albumen composition, it is characterised in that: using such as claim 1-4 Metal oxide nano made from a kind of any metal oxide nano bletilla striata pheretima albumen composition preparation method is white Splendid achnatherum pheretima albumen composition is used as rat brain injury repair medicine.
CN201910024961.9A 2019-01-10 2019-01-10 A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and application Pending CN109529012A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910024961.9A CN109529012A (en) 2019-01-10 2019-01-10 A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910024961.9A CN109529012A (en) 2019-01-10 2019-01-10 A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and application

Publications (1)

Publication Number Publication Date
CN109529012A true CN109529012A (en) 2019-03-29

Family

ID=65834941

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910024961.9A Pending CN109529012A (en) 2019-01-10 2019-01-10 A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and application

Country Status (1)

Country Link
CN (1) CN109529012A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111621373A (en) * 2020-07-08 2020-09-04 陕西中医药大学 Medicated soap containing earthworm protein extract and preparation method thereof
CN111743997A (en) * 2020-07-08 2020-10-09 陕西中医药大学 Paste traditional Chinese medicine composition based on earthworm protein paste and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103231069A (en) * 2013-03-22 2013-08-07 常州大学 Preparation method for hollow nano metal
CN104150451A (en) * 2014-08-06 2014-11-19 陕西科技大学 Preparation method for nickel phosphide with hollow core-shell structure
CN108498499A (en) * 2018-03-07 2018-09-07 兰州大学 The anti-neurotrosis method of ischemic brain damage animal model
CN108837140A (en) * 2018-06-26 2018-11-20 陕西中医药大学 A kind of preparation method and application of pheretima protein microsphere nanometer wound compound
CN109045069A (en) * 2018-11-09 2018-12-21 四川农业大学 A kind of pheretima syrup nano-silver water gel patch and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103231069A (en) * 2013-03-22 2013-08-07 常州大学 Preparation method for hollow nano metal
CN104150451A (en) * 2014-08-06 2014-11-19 陕西科技大学 Preparation method for nickel phosphide with hollow core-shell structure
CN108498499A (en) * 2018-03-07 2018-09-07 兰州大学 The anti-neurotrosis method of ischemic brain damage animal model
CN108837140A (en) * 2018-06-26 2018-11-20 陕西中医药大学 A kind of preparation method and application of pheretima protein microsphere nanometer wound compound
CN109045069A (en) * 2018-11-09 2018-12-21 四川农业大学 A kind of pheretima syrup nano-silver water gel patch and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
上海第一医学院华山医院: "《外科学》", 30 December 1975, 人民卫生出版社 *
吴浩: "过渡金属磷化物纳米结构的可控合成、表征及其性能研究", 《中国优秀硕士论文全文数据库,工程科技I辑》 *
王钰佳等: "本体磷化镍的水热合成研究", 《应用化工》 *
罗旭东等: "Ni2P的水热合成与表征", 《应用化工》 *
郭成周等: "创伤愈合促进剂的初步观察", 《苏联医学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111621373A (en) * 2020-07-08 2020-09-04 陕西中医药大学 Medicated soap containing earthworm protein extract and preparation method thereof
CN111743997A (en) * 2020-07-08 2020-10-09 陕西中医药大学 Paste traditional Chinese medicine composition based on earthworm protein paste and preparation method thereof

Similar Documents

Publication Publication Date Title
DE69912998T2 (en) HEART VALVE AND METHOD FOR PRODUCING A BIOLOGICAL TISSUE
EP1637147A1 (en) Stable dust extract for allergy protection
CN101040867A (en) Application of fucoidan in the preparation of medicine and health-care products for preventing and treating neurodegenerative diseases
CN109529012A (en) A kind of metal oxide nano bletilla striata pheretima albumen composition preparation method and application
Zhang et al. A bilayered PLGA/multiwall carbon nanotubes/bacterial cellulose composite membrane for tissue regeneration of maxillary canine periodontal bone defects
CN1202103C (en) Preparation method of red sageroot total phenolic acid and its use
CN107519534A (en) The preparation method that polyethyleneglycol modified graphene oxide carries the 3D medicine compound rests of quercetin crosslinking acellular dermal matrix
CN110090307A (en) A kind of load medicine black phosphorus chitosan composite Nano ball and its preparation method and application
DE102019132865B4 (en) METHOD AND DEVICE FOR THE ANALYSIS OF TISSUE SAMPLES
CN106177901A (en) A kind of pudendum facial film
US20210403338A1 (en) Dual light-responsive zinc oxide and preparation method thereof as well as photosensitive coating with antibacterial/osteogenic properties
EP2538948A1 (en) Biodegradable material containing silicon, for pro-angiogenetic therapy
Ubelaker et al. Surface topography of Hymenolepis diminuta by scanning electron microscopy
EP0862907B1 (en) Protein extract from cereal gluten
CN116211777A (en) Whitening acne-removing cosmetic and preparation process thereof
CN1299753C (en) Chinese medicinal composition, its preparation method and quality control method
CN106474533A (en) A kind of it is applied to combine dressing of the surface of a wound and preparation method thereof
EP2392644B1 (en) In vitro test system for viral infections
CN113143788A (en) Multi-effect composition and face cream with moisturizing, repairing and relieving functions
DE60222993T2 (en) Composition of traditional Chinese medicines for the prophylaxis and treatment of cerebrovascular diseases
CN115607726B (en) Rhubarb charcoal-chitosan-silk fibroin composite material and preparation method and application thereof
CN113876738B (en) A quercetin nanometer slow release preparation for safely and effectively resisting pneumoconiosis fibrosis, and its preparation method
CN108187013A (en) Wen Tongshu network compositions and preparation method and application
CN108578445A (en) Cortex Ilicis Rotundae extract and its preparation and the application for treating hepatitis
CN109432068B (en) It is a kind of to treat treating echinococcosis composition and pharmaceutical preparation and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190329